Form 4 Tracker
AbCellera Biologics Inc.
ABCL

13 insider filings · Latest: Aug 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 14, 2026Aug 14 4:04 PMAndrew BoothChief Financial Officer
Purchase
37,200$10.32$383.9K482,800(D)

View →

Aug 12, 2026Aug 14 3:50 PMMichael R HaydenDirector
Purchase
46,387$10.37$481.0K1,319,784(I)

View →

May 14, 2026May 18 4:09 PMJohn S. MontalbanoDirector
Purchase
20,000$4.77$95.4K241,000(D)

View →

Feb 27, 2026Mar 2 7:16 PMThermopylae Holdings Ltd.10% Owner
Purchase
38,000$3.44$130.7K56,134,097(D)

View →

Feb 26, 2026Feb 27 9:20 PMThermopylae Holdings Ltd.10% Owner
Purchase
177,457$3.27$580.3K56,096,097(D)

View →

Feb 27, 2026Feb 27 7:48 PMAndrew BoothChief Financial Officer
Purchase
42,600$3.42$145.7K195,600(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 6 10:20 PMLynn SeelyDirector
Grant/Award
152,207$7.85152,207(D)

View →

Jul 1, 2026Jul 6 10:04 PMVictor SandorDirector
Grant/Award
152,207$7.85152,207(D)

View →

Jun 11, 2026Jun 12 5:04 PMMichael R HaydenDirector
Grant/Award
111,701$5.271,011,544(D)

View →

Jun 11, 2026Jun 12 5:03 PMStephen QuakeDirector
Grant/Award
111,701$5.27306,633(D)

View →

Jun 11, 2026Jun 12 5:02 PMJohn S. MontalbanoDirector
Grant/Award
111,701$5.271,141,544(D)

View →

Jun 3, 2026Jun 3 6:23 PMAndrew BoothChief Financial Officer
Option Exercise
250,000$0.198,501,849(D)

View →